Article
Pathological Mechanistic Studies of Osimertinib Resistance in Non-Small-Cell Lung Cancer…
Journal of Oncology · 2019 · Qing Ma, author Jing Wang, author Yaoyao Ren, author Fanlu Meng, author Lili Zeng, author San-Lin You, Academic Editor
Key facts
| Title | Pathological Mechanistic Studies of Osimertinib Resistance in Non-Small-Cell Lung Cancer Cells Using an Integrative Metabolomics-Proteomics Analysis |
|---|---|
| First author | Qing Ma, author Jing Wang, author Yaoyao Ren, author Fanlu Meng, author Lili Zeng, author San-Lin You, Academic Editor |
| Journal | Journal of Oncology |
| Published | Dec 5, 2019 |
| DOI | 10.1155/2020/6249829 |
| Devices mentioned | DEN000008, K022086, K941346, K973350, K990827 |
| Product codes mentioned | CIT, JCI, KIT, MVU, NDS, NJT, DDX, JLX, KQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1